บรรณานุกรม ของ อิริโทรมัยซิน

1 2 3 4 5 6 7 8 Lacy FC, Armstrong LL, Goldman PM, Lance LL, editors. Drug Information Handbook with international trade name index. 18th edition, New Tork, Lexi-Comp®, 2014, p. 585-588, ISBN 978-1-59195-255-8
1 2 Gilbert DN, Chambers FH, Elliopoulos MG, Saag SM, et al. The Sandford Guide to Antimicrobial Therapy. 44th edition, Sperryville (VA), Sandford Guide, 2014, p. 66-71, ISBN 978-1-9308-0878-2
1 2 EspaceNet. "Bibliographic data: US2653899 (A) ― 1953-09-29". สืบค้นเมื่อ 16 August 2015.
1 2 Thomas J. Dougherty and Michael J. Pucci (2011). "Antibiotic Discovery and Development". Springer. doi:10.1007/978-1-4614-1400-1. ISBN 978-1-4614-1399-8.
1 2 Centers for Disease Control and Prevention. "Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2006: Fluoroquinolones No Longer Recommended for Treatment of Gonococcal Infections". Department of Health and Human Services. สืบค้นเมื่อ 9 August 2015.
1 2 M. Camilleri, H.P. Parkman, M.A. Shafi, T.L. Abell and L. Gerson (2013). "Management of Gastroparesis". Am J Gastroenterol. 108: 18–37. doi:10.1038/ajg.2012.373.CS1 maint: multiple names: authors list (link)
1 2 R. W. McCallum and O. Cynshi (2007). "Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis – a randomized, multicentre, placebo-controlled study". Aliment Pharmacol Ther. pp. 1121–1130. สืบค้นเมื่อ 16 August 2015.
↑ P. F. Wiley , K. Gerzon , E. H. Flynn , M. V. Sigal Jr., O. Weaver , U. C. Quarck , R.R. Chauvette , R. Monahan (1957). "Erythromycin. X.1 Structure of Erythromycin". J. Am. Chem. Soc. 79 (22): 6062–6070. doi:10.1021/ja01579a059.CS1 maint: multiple names: authors list (link)
↑ "WHO Model List of Essential Medicines" (PDF). World Health Organization. October 2013. สืบค้นเมื่อ 22 April 2014.
↑ Florence F. Hibionada (2005). "Remembering the battle of Dr. Abelardo Aguilar:Cure for millions, deprived of millions". The News Today. สืบค้นเมื่อ 16 August 2015.
↑ Johanna Son (1994). "MEDICINE-PHILIPPINES: Who Really Discovered Erythromycin ? (1) An Inter Press Service Feature". Inter Press Service News Agency. สืบค้นเมื่อ 16 August 2015.
↑ Robert C. Anderson, Paul N. Harris andK. K. Chen (1955). "Further toxicological studies with ilotycin® (Erythromycin, Lilly)". Journal of the American Pharmaceutical Association. 44 (4): 199–204. doi:10.1002/jps.3030440404.
↑ Nobel Media AB2015 (2015). "Robert B. Woodward - Biographical". Nobel Prize Prganization. สืบค้นเมื่อ 16 August 2015.
1 2 Woodward R. B., Logusch E., Nambiar K. P., Sakan K., Ward D. E., Au-Yeung , Balaram P., Browne L. J., Card P. J.; และคณะ (1981). "Asymmetric Total Synthesis of Erythromycin. 1. Synthesis of an Erythronolide A Seco Acid Derivative via Asymmetric Induction". J. Am. Chem. Soc. 103 (11): 3210–3213. doi:10.1021/ja00401a049.CS1 maint: multiple names: authors list (link)
1 2 Woodward R. B., Logusch E., Nambiar K. P., Sakan K., Ward D. E., Au-Yeung , Balaram P., Browne L. J., Card P. J.; และคณะ (1981). "Asymmetric Total Synthesis of Erythromycin. 2. Synthesis of an Erythronolide A Lactone System". J. Am. Chem. Soc. 103 (11): 3213–3215. doi:10.1021/ja00401a050.CS1 maint: multiple names: authors list (link)
1 2 Woodward R. B., Logusch E., Nambiar K. P., Sakan K., Ward D. E., Au-Yeung , Balaram P., Browne L. J., Card P. J.; และคณะ (1981). "Asymmetric Total Synthesis of Erythromycin. 3. Total Synthesis of Erythromycin". J. Am. Chem. Soc. 103 (11): 3215–3217. doi:10.1021/ja00401a051.CS1 maint: multiple names: authors list (link)
↑ Project Gutenberg Self-Publishing Press (2015). "CLARITHROMYCIN". สืบค้นเมื่อ 16 August 2015.
↑ Peeters TL (2001). "GM-611 (Chugai Pharmaceutical)". Curr Opin Investig Drugs. 2 (4): 555–557. PMID 11566017.
↑ Kenji Yogo, Mitsu Onoma, Ken-ichi Ozaki, Masao Koto, Zen Itoh, and Satoshi ÅŒmura (2008). "Effects of Oral Mitemcinal (GM-611), Erythromycin, EM-574 and Cisapride on Gastric Emptying in Conscious Rhesus MonkeysEffects of Oral Mitemcinal (GM-611), Erythromycin, EM-574 and Cisapride on Gastric Emptying in Conscious Rhesus Monkeys". Digestive Diseases & Sciences. 53 (4): 912. C1 control character in |author= at position 77 (help)CS1 maint: multiple names: authors list (link)
↑ Weber FH Jr; และคณะ (April 1993). "Erythromycin: a motilin agonist and gastrointestinal prokinetic agent". American Journal of Gastroenterology. 88 (4): 485–90. PMID 8470625. Explicit use of et al. in: |author= (help)
↑ V. J. Kopp, D. C. Mayer, and N. J. Shaheen (1997). "Intravenous Erythromycin Promotes Gastric Emptying Prior to Emergency Anesthesia". Anesthesiology. 87: 703–705.CS1 maint: multiple names: authors list (link)
↑ N. S. Winstead, and C. M. Wilcox (2007). "Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis". Alimentary Pharmacology & Therapeutics. 26 (10): 1371–1377.
↑ A. Ahmed,and S. Quraishi (2006). "Aetiological causes of reversible sensorineural hearing loss". The Internet Journal of Otorhinolaryngology. 6 (2).
↑ R.E. Brummett, and K. E. Fox (1989). "Vancomycin- and Erythromycin-Induced Hearing Loss in Humans" (PDF). Antimicrobial Agents and Chemotherapy. 6 (2): 791–796.
↑ J. Dylewski (1988). "Irreversible sensorineural hearing loss due to erythromycin". CMAJ. 139 (3): 230–231. PMC 1268068.
1 2 Lexicomp® OnlineTM. "Pregnancy and Lactation". สืบค้นเมื่อ 16 August 2015.
1 2 Maheshwai N (March 2007). "Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis?". Arch. Dis. Child. 92 (3): 271–3. doi:10.1136/adc.2006.110007. PMC 2083424. PMID 17337692.
↑ M. Lund, B. Pasternak, R. B. Davidsen, B. Feenstra, C. Krogh, L. J. Diaz, J. Wohlfahrt, and M. Melbye (2014). "Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study". BMJ. 348: g1908. doi:10.1136/bmj.g1908.CS1 maint: multiple names: authors list (link)
↑ McCormack WM, George H, Donner A, Kodgis LF, Albert S, Lowe EW, Kass EH (1997). "Hepatotoxicity of erythromycin estoate during pregnancy". Antimicrob Agents Chemother. 12 (5): 630–5. doi:10.1128/AAC.12.5.630. PMC 429989. PMID 21610.CS1 maint: multiple names: authors list (link)
1 2 Belgisch Centrum voor Farmacotherapeutische Informatie. "Erythromycin". สืบค้นเมื่อ 20 July 2008.
1 2 Hunt M.C., Watcins B.P., Saenger P., Stave M.G., Barlascini N., Watlington O.C., Wright T.J., and Guzelain S.P. (1992). "Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol". Clinical Pharmacology and Therapeutics. 51 (1): 18–23. doi:10.1038/clpt.1992.3.CS1 maint: multiple names: authors list (link)
↑ Pal S (2006). "A journey across the sequential development of macrolides and ketolides related to erythromycin". Tetrahedron. 62 (14): 3171–3200. doi:10.1016/j.tet.2005.11.064.
↑ Evans D. A., Kim A. S. (1997). "Synthesis of 6-Deoxyerythronolide B. Implementation of a General Strategy for the Synthesis of Macrolide Antibiotics". Tetrahedron Lett. 38: 53–56. doi:10.1016/S0040-4039(96)02258-7.
1 2 Drugs.com. "erythromycin (Oral route, Parenteral route)". สืบค้นเมื่อ 16 August 2015.
↑ I. O. Kibwage, J. Hoogmartens, E. Roets, H. Vanderhaeghe, L. Verbist, M. Dubost, C. Pascal, P. Petitjean, and G. Levol (1985). "Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives". Antimicrob Agents Chemother. 28 (5): 630–633. PMC 176346.CS1 maint: multiple names: authors list (link)
↑ TOKU-E. "Erythromycin A, EvoPure® Susceptibility and Minimum Inhibitory Concentration (MIC) Data Issue date 08/15/2015" (PDF). สืบค้นเมื่อ 16 August 2015.
↑ Connie R. Mahon, Donald C. Lehman, and George Manuselis Jr (2011). Textbook of Diagnostic Microbiological. W.B. Saunders Company, ISBN 978-1-1460-6165-6
1 2 Katzung PHARMACOLOGY, 9e Section VIII. Chemotherapeutic Drugs Chapter 44. Chloramphenicol, Tetracyclines, Macrolides, Clindamycin, & Streptogramins
↑ J R Menninger and D P Otto (1982). "Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes". Antimicrob Agents Chemother. 21 (5): 811–818. doi:10.1128/AAC.21.5.811.
↑ Martina Bosnar, Željko Kelnerić, Vesna Munić, Vesna Eraković, and Michael J. Parnham (2005). "Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin". Antimicrob Agents Chemother. 49 (6): 2372–2377. doi:10.1128/AAC.49.6.2372-2377.2005.CS1 maint: multiple names: authors list (link)
1 2 3 Lexicomp® OnlineTM. "Erythromycin". สืบค้นเมื่อ 16 August 2015.
↑ America academy of Padiatrics: committee on drug. "The Transfer of Drugs and Other Chemicals Into Human Milk" (PDF). The American Association of Pediatrics. สืบค้นเมื่อ 16 August 2015.
↑ Matsuda S. (1984). "Transfer of antibiotics into maternal milk". Biol Res Pregnancy Perinatol. 5 (2): 57–60. PMID 6743732.
↑ Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, and Stein CM (2004). "Erythromycin and the Risk of Sudden Death from Cardiac Causes". N Engl J Med. 351: 1089–96. doi:10.1056/NEJMoa040582.CS1 maint: multiple names: authors list (link)
↑ A Ahmed, and Z Simmons (2008). "Drugs Which May Exacerbate or Induce Myasthenia Gravis: A Clinician's Guide Drugs Which May Exacerbate or Induce Myasthenia Gravis: A Clinician's Guide". The Internet Journal of Neurology. 10 (2): 1–7.
↑ RxList Inc. "Cleosin (Clindamycin) Drug Interaction". สืบค้นเมื่อ 17 August 2015.
↑ WebMD. "Interaction between Clindamycin HCl oral and lincosamides-erythromycin". สืบค้นเมื่อ 17 August 2015.
↑ Pena-Miller A.P., H. Beardmore , R.R.Laehnemann, D. Jansen, G. Fuentes-Hernandez, A. Rosenstiel, P. Schulenburg, H.R. Beardmore (April 23, 2013). "When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition". PLOS Biology. 4 (11): e1001540. PMID 23630452. |access-date= requires |url= (help)CS1 maint: multiple names: authors list (link)